575 related articles for article (PubMed ID: 25634357)
1. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
2. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
[TBL] [Abstract][Full Text] [Related]
3. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
5. A New View of Vitiligo: Looking at Normal-Appearing Skin.
Picardo M; Bastonini E
J Invest Dermatol; 2015 Jul; 135(7):1713-1714. PubMed ID: 26066890
[TBL] [Abstract][Full Text] [Related]
6. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
7. Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo.
Kim JY; Lee EJ; Seo J; Oh SH
Br J Dermatol; 2017 Jun; 176(6):1558-1568. PubMed ID: 27787879
[TBL] [Abstract][Full Text] [Related]
8. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
9. Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology.
Yamamoto A; Yang L; Kuroda Y; Guo J; Teng L; Tsuruta D; Katayama I
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383933
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo Skin: Exploring the Dermal Compartment.
Kovacs D; Bastonini E; Ottaviani M; Cota C; Migliano E; Dell'Anna ML; Picardo M
J Invest Dermatol; 2018 Feb; 138(2):394-404. PubMed ID: 29024688
[TBL] [Abstract][Full Text] [Related]
12. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
Kumar R; Parsad D; Kanwar AJ; Kaul D
Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
[TBL] [Abstract][Full Text] [Related]
14. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo.
Zailaie MZ
Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153
[TBL] [Abstract][Full Text] [Related]
15. Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment.
Bzioueche H; Boniface K; Drullion C; Marchetti S; Chignon-Sicard B; Sormani L; Rocchi S; Seneschal J; Passeron T; Tulic MK
Br J Dermatol; 2023 Aug; 189(3):312-327. PubMed ID: 37140010
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo.
Jimbow K; Chen H; Park JS; Thomas PD
Br J Dermatol; 2001 Jan; 144(1):55-65. PubMed ID: 11167683
[TBL] [Abstract][Full Text] [Related]
17. Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study.
Benzekri L; Hmamouchi I; Gauthier Y
Br J Dermatol; 2015 Feb; 172(2):331-6. PubMed ID: 24902987
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
20. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
Gauthier Y; Cario Andre M; Taïeb A
Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
